Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|January 30, 2019
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)Jean-Pascal Machiels, Ramon Salazar, Sylvie Rottey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumorsIgnacio Duran, Sebastien J Hotté, Holger Hirte, et al.
Journal for Immunotherapy of Cancer|September 20, 2017
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resectionRocio Garcia-Carbonero, Ramon Salazar, Ignacio Duran, et al.
The Lancet. Oncology|October 16, 2023
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trialMarc-Oliver Grimm, Emilio Esteban, Philippe Barthélémy, et al.
European Urology|December 31, 2010
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experienceJeremy F Sturgeon, Malcolm J Moore, David M Kakiashvili, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 11, 2023
Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experienceMarina Serrano, Nerea Muñoz-Unceta, Lucía Andrea Alonso, et al.
Acta Oncologica (Stockholm, Sweden)|November 5, 2021
Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR studyManuela Schmidinger, Robert J Motzer, Frederic Rolland, et al.
Critical Reviews in Oncology/Hematology|May 20, 2020
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)Christian Rolfo, Andrés F Cardona, Massimo Cristofanilli, et al.
Molecular Cancer Therapeutics|March 4, 2010
Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohortMiguel Quintela-Fandino, Christophe Le Tourneau, Ignacio Duran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumorsLillian L Siu, Roberto Pili, Ignacio Duran, et al.
Pageof 9